Linear reduction of clonal cells in stem cell enriched grafts in transplanted multiple myeloma

British Journal of Haematology

Volumn 104, Issue 3, 1999, Pages 546-552

  Thunberg, U ^b   Banghagen, M ^c   Bengtsson, M ^c   Christensen, L D ^a   Geisler, C H ^a   Gimsing, P ^a   Lenhoff, S ^c   Mortensen, B T ^a   Olofsson, T ^c   Simonsson, B ^c   Andersen, N Smedegaard ^a   Sundstrom C ^c   Swedin, A ^c   Sallstrom J F ^c   Thuresson, B ^c   Westin, J ^c   Carlson, K ^c  

^a Rigshospitalet   (Denmark)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c NONE

Author keywords

Autologous bone marrow transplantation; CD34+ cells; Immunoglobulin; Multiple myeloma; PCR

Indexed keywords

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LEUKAPHERESIS; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0033026351     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01215.x     Document Type: Article

References (27)

1. Alexanian, R. & Dimopoulos, M. (1994) The treatment of multiple myeloma. New England Journal of Medicine, 330, 484-489.
2. Attal, M., Harousseau, J.L., Stoppa, A.M., Sotto, J.J., Fuzibet, J.G., Rossi, J.F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., Payen, C. & Bataille, R. (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myelome. New England Journal of Medicine, 335, 91-97.
3. + peripheral blood stem cells in patients with advanced hematologic malignancy. Blood, 88, 4132-4138.
4. Blade, J., Kyle, R.A. & Greipp, P.R. (1996) Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years. British Journal of Haematology, 93, 345-351.
5. Brenner, M.K., Rill, D.R., Moen, R.C., Krance, R.A., Heslop, H.E., Mirro, J.J., Anderson, W.F. & Ihle, J.N. (1994) Gene marking and autologous bone marrow transplantation. Annals of the New York Academy of Sciences, 716, 204-214.
6. Deane, M., McCarthy, K.P., Wiedemann, L.M. & Norton, J.D. (1991) An improved method for detection of B-lymphoid clonality by polymerase chain reaction. Leukemia, 5, 726-730.
7. Deane, M. & Norton, J.D. (1990) Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias. European Journal of Immunology, 20, 2209-2217.
8. Deane, M. & Norton, J.D. (1991) Immunoglobulin gene 'fingerprinting': an approach to analysis of B lymphoid clonality in lymphoproliferative disorders. British Journal of Haematology, 77, 274-281.
9. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood, 83, 3068-3076.
10. Freedman, A.S., Gribben, J.G., Neuberg, D., Mauch, P., Soiffer, R.J., Anderson, K.C., Pandite, L., Robertson, M.J., Kroon, M., Ritz, J. & Nadler, L.M. (1996) High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood, 88, 2780-2786.
11. + stem cells do not contain clonal myeloma cells. Blood, 86, 381-389.
12. Gorin, N.C., Aegerter, P., Auvert, B., Meloni, G., Goldstone, A.H., Burnett, A., Carella, A., Korbling, M., Herve, P., Maraninchi, D., Löwenberg, R., Verdonck, L.F., de Planque, M., Hermans, J., Helbig, W., Porcellini, A., Rizzoli, V., Alexandrino, E.P., Franklin, I.M., Reiffers, J., Colleselli, P. & Goldman, J.M. (1990) Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Blood, 75, 1606-1614.
13. + bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood, 85, 1647-1654.
14. Heid, C.A., Stevens, J., Livak, K.J. & Williams, P.M. (1996) Real time quantitative PCR. Genome Research, 6, 986-994.
15. + cell analysis: technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. Nordic Myeloma Study Group Laboratories. Journal of Hematotherapy, 4, 21-28.
16. + cell enumeration in blood and leukapheresis products: report from the second Nordic Workshop. Nordic Stem Cell Laboratory Group (NSCL-G). Journal of Hematotherapy. 5, 237-245.
17. Kalinina, O., Lebedeva, I., Brown, J. & Silver, J. (1997) Nanoliter scale PCR with TaqMan detection. Nucleic Acids Research, 25, 1999-2004.
18. + cells to remove circulating tumor cells. Bood, 87, 1625-1634.
19. Ouspenskaia, M.V., Johnston, D.A., Roberts, W.M., Estrov, Z. & Zipf, T.F. (1995) Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved. Leukemia, 9, 321-328.
20. + peripheral blood progenitor cells into multiple myeloma patients following total body irradiation. Nouvelle Revue Française d'Hématologie, 37, 381-383.
21. Pilarski, L.M. & Jensen, G.S. (1992) Monoclonal circulating B cells in multiple myeloma: a continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules. Hematology/Oncology Clinics of North America, 6, 297-322.
22. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood, 86, 390-397.
23. + cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ gene rearrangement. Blood, 89, 1824-1833.
24. Takishita, M., Kosaka, M., Goto, T. & Saito, S. (1994) Cellular origin and extent of clonal involvement in multiple myeloma: genetic and phenotypic studies. British Journal of Haematology, 87, 735-742.
25. Thunberg, U., Alemi, M., Sundström, C. & Sällström, J. (1995) Nonradioactive detection of monoclonal immunoglobulin heavy chain gene rearrangement with PCR-SSCP. Hematological Pathology, 9, 141-153.
26. Vescio, R., Cao, J., Hong, C., Newan, R., Lichtenstein, A. & Berenson, J. (1993) Somatic hypermutation of VH genes in multiple myeloma is unaccompanied by intraclonal diversity Blood, 82, (Suppl.), 259a.
27. Vescio, R.A., Hong, C.H., Cao, J., Kim, A., Schiller, G.J., Lichtenstein, A.K., Berenson, R.J. & Berenson, J.R. (1994) The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma. Blood, 84, 3283-3290.